MCRB Annual Operating Profit
-$107.98 M
+$138.51 M+56.19%
31 December 2023
Summary:
As of January 22, 2025, MCRB annual operaing income is -$107.98 million, with the most recent change of +$138.51 million (+56.19%) on December 31, 2023. During the last 3 years, it has fallen by -$19.85 million (-22.53%). MCRB annual operating profit is now -3460.27% below its all-time high of -$3.03 million, reached on December 31, 2012.MCRB Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MCRB Quarterly Operating Profit
-$29.17 M
+$2.17 M+6.94%
30 September 2024
Summary:
As of January 22, 2025, MCRB quarterly operating income is -$29.17 million, with the most recent change of +$2.17 million (+6.94%) on September 30, 2024. Over the past year, it has dropped by -$79.26 million (-158.24%). MCRB quarterly operating profit is now -142.64% below its all-time high of $68.41 million, reached on September 30, 2021.MCRB Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MCRB TTM Operating Profit
-$50.01 M
+$15.42 M+23.56%
30 September 2024
Summary:
As of January 22, 2025, MCRB TTM operating income is -$50.01 million, with the most recent change of +$15.42 million (+23.56%) on September 30, 2024. Over the past year, it has dropped by -$34.47 million (-221.82%). MCRB TTM operating profit is now -423.86% below its all-time high of $15.44 million, reached on March 31, 2024.MCRB TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MCRB Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +56.2% | -158.2% | -221.8% |
| 3 y3 years | -22.5% | +57.3% | +79.7% |
| 5 y5 years | -7.7% | +57.3% | +79.7% |
MCRB Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -67.4% | +56.2% | -158.2% | +58.7% | -423.9% | +80.9% |
| 5 y | 5-year | -67.4% | +56.2% | -142.6% | +58.7% | -423.9% | +80.9% |
| alltime | all time | -3460.3% | +56.2% | -142.6% | +58.7% | -423.9% | +80.9% |
Seres Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$29.17 M(-6.9%) | -$50.01 M(-23.6%) |
| June 2024 | - | -$31.34 M(-20.8%) | -$65.43 M(-523.7%) |
| Mar 2024 | - | -$39.59 M(-179.0%) | $15.44 M(-199.4%) |
| Dec 2023 | -$107.98 M(-56.2%) | $50.09 M(-212.3%) | -$15.54 M(-88.4%) |
| Sept 2023 | - | -$44.59 M(-190.0%) | -$133.94 M(-9.8%) |
| June 2023 | - | $49.52 M(-170.2%) | -$148.46 M(-43.2%) |
| Mar 2023 | - | -$70.57 M(+3.3%) | -$261.31 M(+6.0%) |
| Dec 2022 | -$246.49 M(+282.2%) | -$68.31 M(+15.6%) | -$246.49 M(+8.3%) |
| Sept 2022 | - | -$59.11 M(-6.7%) | -$227.62 M(+127.4%) |
| June 2022 | - | -$63.33 M(+13.6%) | -$100.10 M(+17.9%) |
| Mar 2022 | - | -$55.75 M(+12.8%) | -$84.92 M(+31.7%) |
| Dec 2021 | -$64.49 M(-26.8%) | -$49.43 M(-172.3%) | -$64.49 M(+95.7%) |
| Sept 2021 | - | $68.41 M(-242.1%) | -$32.96 M(-74.9%) |
| June 2021 | - | -$48.14 M(+36.3%) | -$131.36 M(+26.6%) |
| Mar 2021 | - | -$35.33 M(+97.4%) | -$103.76 M(+17.7%) |
| Dec 2020 | -$88.13 M(+25.2%) | -$17.90 M(-40.3%) | -$88.13 M(-1.4%) |
| Sept 2020 | - | -$30.00 M(+46.0%) | -$89.42 M(+16.7%) |
| June 2020 | - | -$20.55 M(+4.3%) | -$76.61 M(+14.3%) |
| Mar 2020 | - | -$19.69 M(+2.6%) | -$67.02 M(-4.8%) |
| Dec 2019 | -$70.38 M | -$19.19 M(+11.7%) | -$70.38 M(-3.4%) |
| Sept 2019 | - | -$17.18 M(+57.0%) | -$72.86 M(-6.5%) |
| June 2019 | - | -$10.95 M(-52.5%) | -$77.89 M(-18.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$23.06 M(+6.4%) | -$95.08 M(-5.2%) |
| Dec 2018 | -$100.28 M(+9.7%) | -$21.67 M(-2.4%) | -$100.28 M(-7.5%) |
| Sept 2018 | - | -$22.21 M(-21.1%) | -$108.39 M(+15.9%) |
| June 2018 | - | -$28.14 M(-0.5%) | -$93.49 M(-0.3%) |
| Mar 2018 | - | -$28.27 M(-5.1%) | -$93.77 M(+2.6%) |
| Dec 2017 | -$91.39 M(-1.6%) | -$29.77 M(+307.1%) | -$91.39 M(+4.7%) |
| Sept 2017 | - | -$7.31 M(-74.3%) | -$87.29 M(-11.9%) |
| June 2017 | - | -$28.42 M(+9.8%) | -$99.07 M(+0.3%) |
| Mar 2017 | - | -$25.89 M(+0.8%) | -$98.80 M(+6.4%) |
| Dec 2016 | -$92.84 M(+69.2%) | -$25.67 M(+34.4%) | -$92.82 M(+6.8%) |
| Sept 2016 | - | -$19.09 M(-32.1%) | -$86.94 M(+5.5%) |
| June 2016 | - | -$28.14 M(+41.3%) | -$82.41 M(+23.7%) |
| Mar 2016 | - | -$19.92 M(+0.6%) | -$66.61 M(+21.4%) |
| Dec 2015 | -$54.86 M(+263.7%) | -$19.79 M(+35.9%) | -$54.86 M(+29.7%) |
| Sept 2015 | - | -$14.56 M(+18.0%) | -$42.28 M(+35.1%) |
| June 2015 | - | -$12.34 M(+51.1%) | -$31.30 M(+45.1%) |
| Mar 2015 | - | -$8.17 M(+13.2%) | -$21.58 M(+43.1%) |
| Dec 2014 | -$15.08 M(+149.2%) | -$7.21 M(+101.5%) | -$15.08 M(+91.7%) |
| Sept 2014 | - | -$3.58 M(+36.7%) | -$7.87 M(+83.4%) |
| June 2014 | - | -$2.62 M(+56.6%) | -$4.29 M(+156.6%) |
| Mar 2014 | - | -$1.67 M | -$1.67 M |
| Dec 2013 | -$6.05 M(+99.5%) | - | - |
| Dec 2012 | -$3.03 M | - | - |
FAQ
- What is Seres Therapeutics annual operaing income?
- What is the all time high annual operating profit for Seres Therapeutics?
- What is Seres Therapeutics annual operating profit year-on-year change?
- What is Seres Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Seres Therapeutics?
- What is Seres Therapeutics quarterly operating profit year-on-year change?
- What is Seres Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Seres Therapeutics?
- What is Seres Therapeutics TTM operating profit year-on-year change?
What is Seres Therapeutics annual operaing income?
The current annual operating profit of MCRB is -$107.98 M
What is the all time high annual operating profit for Seres Therapeutics?
Seres Therapeutics all-time high annual operaing income is -$3.03 M
What is Seres Therapeutics annual operating profit year-on-year change?
Over the past year, MCRB annual operaing income has changed by +$138.51 M (+56.19%)
What is Seres Therapeutics quarterly operating income?
The current quarterly operating profit of MCRB is -$29.17 M
What is the all time high quarterly operating profit for Seres Therapeutics?
Seres Therapeutics all-time high quarterly operating income is $68.41 M
What is Seres Therapeutics quarterly operating profit year-on-year change?
Over the past year, MCRB quarterly operating income has changed by -$79.26 M (-158.24%)
What is Seres Therapeutics TTM operating income?
The current TTM operating profit of MCRB is -$50.01 M
What is the all time high TTM operating profit for Seres Therapeutics?
Seres Therapeutics all-time high TTM operating income is $15.44 M
What is Seres Therapeutics TTM operating profit year-on-year change?
Over the past year, MCRB TTM operating income has changed by -$34.47 M (-221.82%)